| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |